ChatGPT-Supported Text Messaging Program for Smoking Cessation

NCT ID: NCT07079306

Last Updated: 2025-10-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-01

Study Completion Date

2026-01-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Cessation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Text messages about quitting smoking and access to specialized ChatGPT chatbot

Group Type EXPERIMENTAL

BeFree+Bot

Intervention Type BEHAVIORAL

Text messaging program called BeFree and access to BBot, ChatGPT chatbot

Control

Text messages about quitting smoking

Group Type ACTIVE_COMPARATOR

BeFree

Intervention Type BEHAVIORAL

Text messaging program called BeFree

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BeFree+Bot

Text messaging program called BeFree and access to BBot, ChatGPT chatbot

Intervention Type BEHAVIORAL

BeFree

Text messaging program called BeFree

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* lives in the US
* smoked a cigarette within the last 7 days
* has a mobile phone
* willing to receive text messages about the health effects of smoking on their mobile phone for 30 days

Exclusion Criteria

* none
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

George Washington University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Prolific

Washington D.C., District of Columbia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lorien Abroms, ScD

Role: CONTACT

202-994-3518

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GWUniversity

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PASCAL Feasibility Study
NCT07301151 NOT_YET_RECRUITING NA